Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Al-Waili K
  • Al-Rasadi K
  • Banerjee Y
  • MESH
  • Adrenergic beta-Antagonists
  • Humans
  • Hypertension
  • Incidence
  • Neoplasms
  • Prognosis
  • Risk Factors

Unbound MEDLINE

Will β-blockers live up to the maxim of Sir James Black, their creator?

Links

  • Publisher Full Text

    • Authors

    Al-Waili K, Al-Rasadi K, Banerjee Y

    Institution

    Department of Clinical Biochemistry, Sultan Qaboos University, Al-Khod, Muscat, Sultanate of Oman.

    Source

    Angiology 63:6 2012 Aug pg 409-11

    MeSH

    Adrenergic beta-Antagonists
    Humans
    Hypertension
    Incidence
    Neoplasms
    Prognosis
    Risk Factors

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    22718079

    Related Citations

    • [Hypertension and cardiac arrhythmias. Beta blockers frequently help, but not always].
    • [New aspects of differential therapy of arterial hypertension with beta-blockers].
    • Hypertension in diabetes mellitus: role of beta-blockers.
    • Beta-blockers: no longer an option for uncomplicated hypertension.
    • Beta-adrenergic blocking drugs in the treatment of hypertension.
    • [Alpha beta-blockers for patients with hypertension].
    • The evolving role of β-adrenergic receptor blockers in managing hypertension.
    • [The beta-blockers in hypertension].
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved